Skip to main content
. 2018 Jun 25;18:688. doi: 10.1186/s12885-018-4610-4

Table 1.

Pancreatic adenocarcinoma Incidence rates (1973-2014)

Characteristic Incidence of pancreatic adenocarcinoma Incidence of adenocarcinoma of the head of pancreas Incidence of adenocarcinoma of the body and tail of pancreas
Cases, No (%)a Rate (95% CI)b Cases, No (%)a Rate (95% CI)b Cases, No (%)a Rate (95% CI)b
Overall 67,878 (100) 6.95 (6.90 - 7.00) 33,728 (100) 3.46 (3.42 - 3.50) 14,321 (100) 1.46 (1.43 - 1.48)
Sex
 Male 35,062 (51.65) 8.16 (8.07 - 8.24) 17,033 (50.50) 3.98 (3.92 - 4.04) 7,666 (53.53) 1.76 (1.72 - 1.81)
 Female 32,816 (48.35) 5.99 (5.93 - 6.06) 16,695 (49.50) 3.05 (3.00 - 3.09) 6,655 (46.47) 1.22 (1.19 - 1.25)
Race
 White 55,222 (81.35) 6.77 (6.71 - 6.83) 27,492 (81.51) 3.37 (3.33 - 3.42) 11,414 (79.70) 1.40 (1.37 - 1.42)
 Black 7,797 (11.49) 9.85 (9.63 -10.08) 3,961 (11.74) 5.02 (4.86 - 5.19) 1,727 (12.06) 2.16 (2.05 - 2.27)
 Othersc 4,755 (7.01) 5.80 (5.63 - 5.97) 2,229 (6.61) 2.72 (2.61 - 2.84) 1,153 (8.05) 1.39 (1.31 - 1.48)
 Unknownd 104 (0.15) - 46 (0.14) - 27 (0.19) -
Age at diagnosis, y
 <60 16,305 (24.02) 1.93 (1.90 - 1.96) 7,729 (22.92) 0.92 (0.90- 0.94) 3,750 (26.19) 0.44 (0.43 - 0.46)
 >60 51,573 (75.98) 32.28 (32.00 - 32.56) 25,999 (77.08) 16.30 (16.10 - 16.50) 10,571 (73.81) 6.58 (6.46 - 6.71)
Statee
 California 10,960 (16.15) 7.06 (6.93 - 7.20) 5,563 (16.49) 3.60 (3.50 - 3.69) 2,347 (16.39) 1.50 (1.44-1.56)
 Connecticut 10,906 (16.07) 7.41 (7.27 - 7.55) 5,363 (15.90) 3.64 (3.54 - 3.74) 2,306 (16.10) 1.57 (1.51-1.63)
 Georgia 5,113 (7.53) 7.09 (6.89 - 7.29) 2,585 (7.66) 3.61 (3.46 - 3.75) 1,178 (8.22) 1.61 (1.52-1.71)
 Hawaii 2,955 (4.35) 6.47 (6.23 - 6.71) 1,316 (3.90) 2.88 (2.73 - 3.04) 700 (4.89) 1.53 (1.41-1.64)
 Iowa 9,079 (13.38) 6.75 (6.61 - 6.89) 4,631 (13.73) 3.42 (3.33 - 3.53) 1,941 (13.55) 1.46 (1.39-1.52)
 Michigan 12,539 (18.47) 7.87 (7.73 - 8.01) 6,182 (18.33) 3.89 (3.79 - 3.99) 2,556 (17.85) 1.60 (1.53-1.66)
 New Mexico 3,890 (5.73) 6.09 (5.89 - 6.28) 1,928 (5.72) 3.01 (2.87 - 3.15) 671 (4.69) 1.04 (0.96-1.12)
 Utah 3,172 (04.67) 5.32 (5.13 - 5.51) 1,581 (4.69) 2.67 (2.54 - 2.81) 667 (4.66) 1.11 (1.02-1.19)
 Washington 9,264 (13.65) 6.68 (6.55 - 6.82) 4,579 (13.58) 3.31 (3.22 - 3.41) 1,955 (13.65) 1.40 (1.34-1.47)
Stage at diagnosisf
 Localized 5,796 (8.54) 0.60 (0.58 - 0.62) 3,678 (10.90) 0.38 (0.37 - 0.40) 1,123 (7.84) 0.11 (0.11 - 0.12)
 Regional 18,623 (27.43) 1.90 (1.88 - 1.93) 13,193 (39.12) 1.35 (1.33 - 1.37) 2,140 (14.94) 0.22 (0.21 - 0.23)
 Distant 38,852 (57.24) 3.96 (3.92 - 3.998) 14,685 (43.54) 1.50 (1.47 - 1.52) 10,600 (74.02) 1.08 (1.06 - 1.10)
 Unstaged 4,607 (6.79) 0.48 (0.47-0.50) 2,172 (6.44) 0.23 (0.22-0.24) 458 (3.20) 0.05 (0.04-0.05)

aCases included first primary tumors that matched the selection criteria, were microscopically confirmed, and were not identified only from autopsy records

or death certificates

bRates were calculated as number of cases per 100,000 person-years and age adjusted to the 2000 US standard population

cIncludes American Indian/Alaskan Native and Asian/Pacific Islander

dRates for patients with unknown race could not be calculated, as ‘race’ is a population variable and must be known to calculate rates

eRates were calculated between 1973-2014 for all states except Georgia; 1975-2014, and Washington; 1974-2014

fUsing SEER historic stage A